Safety of CHIR-258 (TKI258) in Advanced Solid Tumors
Clinical trial NCT01270906 · TERMINATED
Trial details
- NCT number
- NCT01270906
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.